Total Payments
$515,744
2024 Payments
$39,221
Companies
29
Transactions
847
Medicare Patients
4,135
Medicare Billing
$489,181
Payment Breakdown by Category
Other$355,875 (69.0%)
Consulting$59,672 (11.6%)
Travel$57,806 (11.2%)
Food & Beverage$35,123 (6.8%)
Research$6,810 (1.3%)
Education$456.66 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $354,837 | 126 | 68.8% |
| Consulting Fee | $59,672 | 24 | 11.6% |
| Travel and Lodging | $57,806 | 200 | 11.2% |
| Food and Beverage | $35,123 | 470 | 6.8% |
| Unspecified | $6,810 | 17 | 1.3% |
| Honoraria | $1,000 | 1 | 0.2% |
| Education | $456.66 | 8 | 0.1% |
| Grant | $38.86 | 1 | 0.0% |
Payments by Type
General
$508,934
830 transactions
Research
$6,810
17 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $141,898 | 155 | $0 (2022) |
| Allergan, Inc. | $82,235 | 94 | $0 (2022) |
| ABBVIE INC. | $62,503 | 57 | $0 (2024) |
| UROVANT SCIENCES INC | $39,226 | 45 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $37,432 | 48 | $0 (2024) |
| Medtronic, Inc. | $35,737 | 163 | $0 (2024) |
| Laborie Medical Technologies Corp. | $34,547 | 23 | $0 (2021) |
| Astellas Pharma Global Development | $28,019 | 24 | $0 (2022) |
| Medtronic USA, Inc. | $18,621 | 106 | $0 (2020) |
| Avadel Specialty Pharmaceuticals, LLC | $13,605 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,221 | 80 | ABBVIE INC. ($14,213) |
| 2023 | $51,309 | 97 | Sumitomo Pharma America, Inc. ($27,603) |
| 2022 | $87,766 | 137 | UROVANT SCIENCES INC ($30,961) |
| 2021 | $37,350 | 88 | Allergan, Inc. ($11,747) |
| 2020 | $42,171 | 72 | Allergan, Inc. ($20,262) |
| 2019 | $73,644 | 106 | Astellas Pharma US Inc ($38,789) |
| 2018 | $107,577 | 163 | Astellas Pharma US Inc ($51,715) |
| 2017 | $76,706 | 104 | Astellas Pharma US Inc ($51,237) |
All Payment Transactions
847 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $9,600.00 | General |
| 12/24/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $203.01 | General |
| 12/24/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | Cash or cash equivalent | $51.62 | General |
| 12/03/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $110.56 | General |
| Category: UROLOGY | ||||||
| 11/08/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/07/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $111.39 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/01/2024 | Boston Scientific Corporation | AMS 800 Artificial Urinary Sphincter (Device) | Food and Beverage | In-kind items and services | $126.02 | General |
| Category: AMS 800_URO | ||||||
| 10/31/2024 | Boston Scientific Corporation | AMS 800 Artificial Urinary Sphincter (Device) | Food and Beverage | In-kind items and services | $133.99 | General |
| Category: AMS 800_URO | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $729.20 | General |
| 10/23/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $363.00 | General |
| 10/21/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $128.10 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/08/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $74.59 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/02/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/14/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/05/2024 | Caldera Medical, Inc | Desara (Device) | Food and Beverage | Cash or cash equivalent | $42.00 | General |
| Category: Urogynaecology | ||||||
| 08/30/2024 | Caldera Medical, Inc | Desara (Device) | Food and Beverage | Cash or cash equivalent | $299.93 | General |
| Category: Urogynaecology | ||||||
| 08/30/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $85.28 | General |
| Category: Urology | ||||||
| 08/30/2024 | BLUEWIND MEDICAL | — | Food and Beverage | In-kind items and services | $31.46 | General |
| 08/27/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $80.68 | General |
| Category: Men's Health | ||||||
| 08/21/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/20/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $158.82 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/20/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/13/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/06/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: Sacral Nerve Stimulation | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Cost, resource utilization, and treatment-taking behaviors among Medicare patients with OAB initiating combination mirabegron and antimuscarinic therapy in the US | Astellas Pharma Global Development | $3,122 | 4 |
| Evaluating and understanding combination therapy decision drivers for the treatment of overactive bladder in the United States | Astellas Pharma Global Development | $2,518 | 9 |
| Cost, resource utilization, and treatment-taking behaviors among Medicare patients with OAB initiating combination mirabegron and antimuscarinic therapy in the?US | Astellas Pharma Global Development | $324.53 | 1 |
| Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States | Astellas Pharma Global Development | $316.67 | 1 |
| TREATMENT PATTERNS AND COSTS AMONG PATIENTS WITH OVERACTIVE BLADDER OAB RECEIVING COMBINATION ORAL THERAPY, SACRAL NERVE STIMULATION SNS, PERCUTANEOUS TIBIAL NERVE STIMULATION PTNS, OR ONABOTULINUMTOXINA | Astellas Pharma Global Development | $300.00 | 1 |
| Treatment patterns and costs among patients with overactive bladder (OAB) receiving combination oral therapy, sacral nerve stimulation (SNS), percutaneous tibial nerve stimulation (PTNS), or onabotulinumtoxinA | Astellas Pharma Global Development | $229.17 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 931 | 5,559 | $415,636 | $101,112 |
| 2022 | 22 | 996 | 6,935 | $513,005 | $125,145 |
| 2021 | 21 | 1,136 | 7,629 | $567,841 | $144,576 |
| 2020 | 23 | 1,072 | 5,124 | $482,179 | $118,348 |
Total Patients
4,135
Total Services
25,247
Medicare Billing
$489,181
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 18 | 4,600 | $85,300 | $22,862 | 26.8% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 104 | 104 | $92,069 | $22,574 | 24.5% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 105 | 106 | $45,894 | $12,045 | 26.2% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 19 | 28 | $31,852 | $7,965 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 86 | $26,946 | $7,349 | 27.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 25 | 26 | $18,101 | $4,420 | 24.4% |
| 51600 | Injection procedure for imaging of bladder during voiding | Office | 2023 | 48 | 48 | $30,431 | $3,968 | 13.0% |
| 74455 | Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | Office | 2023 | 54 | 54 | $14,482 | $3,673 | 25.4% |
| 91120 | Test for tone and sensation of rectum and anus | Office | 2023 | 18 | 18 | $12,131 | $3,190 | 26.3% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 123 | 125 | $20,499 | $2,901 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $9,342 | $2,666 | 28.5% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 18 | 18 | $8,452 | $2,253 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $5,686 | $1,718 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $3,544 | $1,057 | 29.8% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Office | 2023 | 18 | 20 | $3,291 | $879.20 | 26.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 64 | 71 | $2,168 | $557.99 | 25.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 105 | 106 | $3,814 | $502.84 | 13.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 17 | 20 | $1,114 | $360.20 | 32.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 68 | 77 | $519.75 | $169.40 | 32.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 20 | 5,900 | $106,200 | $28,552 | 26.9% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2022 | 94 | 94 | $85,672 | $22,223 | 25.9% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2022 | 97 | 97 | $43,452 | $12,251 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 128 | $40,448 | $11,816 | 29.2% |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | Office | 2022 | 13 | 13 | $59,306 | $11,423 | 19.3% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2022 | 20 | 32 | $36,512 | $9,163 | 25.1% |
About Dr. Stephen Kraus, MD
Dr. Stephen Kraus, MD is a Urology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356458426.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Kraus, MD has received a total of $515,744 in payments from pharmaceutical and medical device companies, with $39,221 received in 2024. These payments were reported across 847 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($354,837).
As a Medicare-enrolled provider, Kraus has provided services to 4,135 Medicare beneficiaries, totaling 25,247 services with total Medicare billing of $489,181. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urogynecology and Reconstructive Pelvic Surgery
- Location San Antonio, TX
- Active Since 08/24/2006
- Last Updated 12/27/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1356458426
Products in Payments
- BOTOX (Biological) $115,715
- MYRBETRIQ (Drug) $93,957
- GEMTESA (Drug) $76,658
- Myrbetriq (Drug) $55,647
- INTERSTIM (Device) $53,154
- BOTOX (Drug) $26,396
- Noctiva (Drug) $13,605
- MIRABEGRON (Drug) $10,652
- VESICARE (Drug) $5,114
- BOTOX OAB (Drug) $2,581
- Axonics (Device) $1,344
- BLUDIGO (Drug) $1,080
- AMS (Device) $839.43
- Bulkamid (Device) $803.56
- Supris (Device) $601.86
- AMS 700 (Device) $544.40
- Desara (Device) $538.30
- INTERSTIM ICON (Device) $465.23
- General - Erectile Dysfunction (Device) $401.74
- ALTIS (Device) $313.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in San Antonio
Dr. Leroy Jones, Md, MD
Urology — Payments: $720,896
Urology $720,896
Daniel Yelfimov, M.d, M.D
Urology — Payments: $207,554
Urology $207,554
Dr. Christopher Cantrill, Md, MD
Urology — Payments: $95,294
Urology $95,294
Dr. Jose De La Cerda, M.d, M.D
Urology — Payments: $92,067
Urology $92,067
Dr. Naveen Kella, M.d, M.D
Urology — Payments: $63,626
Urology $63,626
Robert Svatek, Md, MD
Urology — Payments: $58,084
Urology $58,084